
Abeona Therapeutics Inc
ABEO · NASDAQ · Healthcare / Biotechnology
Price History
Full chartMarket Stats
About
Abeona Therapeutics Inc., a commercial-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases in the United States. It develops ZEVASKYN, an autologous, cell-based gene therapy for the treatment of patients with recessive dystrophic epidermolysis bullosa. The company also develops ABO-503 to treat X-linked retinoschisis; ABO-504 for the treatment of stargardt disease; and ABO-505 to treat autosomal dominant optic atrophy. In addition, it is developing AAV-based gene therapy through its AIM vector platform programs. The company was formerly known as PlasmaTech Biopharmaceuticals, Inc. and changed its name to Abeona Therapeutics Inc. in June 2015. Abeona Therapeutics Inc. was founded in 1974 and is headquartered in Cleveland, Ohio.
Company Details
- SectorHealthcare
- IndustryBiotechnology
- CEODr. Vishwas Seshadri M.B.A., Ph.D.
- Employees226
- Headquarters6555 Carnegie Avenue, Cleveland, OH, United States, 44103, USA
- Websitehttps://www.abeonatherapeutics.com
Leadership
- Dr. Vishwas Seshadri M.B.A., Ph.D.President, CEO & Director · b. 1976
- Mr. Joseph Walter Vazzano CPAChief Financial Officer · b. 1984
- Dr. Brendan M. O'Malley J.D., Ph.D.Chief Legal Officer · b. 1969
- Mr. Brian Kevany Ph.D.Chief Technical & Scientific Officer
- Mr. Gregory GinVice President of Investor Relations & Corporate Communications
- Ms. Gianine EspositoSenior VP & Chief People Officer
- Mr. Jon VossVP & Head of Quality · b. 1960
- Dr. Madhav Vasanthavada M.B.A., Ph.D.SVP, Chief Commercial Officer & Head of Business Development · b. 1979
- Mr. Carl DennySenior Vice President of Regulatory Affairs
- Ms. Megan CallanVice President & Head of Quality
Financials
Income Statement
Balance Sheet
Cash Flow
Earnings
Key Statistics & Ratios
Analyst Ratings
- Strong Buy5
- Buy1
Ownership Breakdown
- Institutions
- 74.89%
- Insiders
- 11.31%
- Retail / Other
- 13.80%
Top Institutional Holders
- Nantahala Capital Management, LLC5.01M8.77%
- BlackRock Inc3.20M5.59%
- Cable Car Capital LLC3.01M5.26%
- AIGH Capital Management, LLC2.99M5.22%
- Suvretta Capital Management, LLC2.68M4.68%
- Vanguard Capital Management, LLC2.16M3.79%
- Resources Investment Advisors Inc1.65M2.89%
- Kennedy Capital Management Inc1.24M2.17%
- Geode Capital Management, LLC1.21M2.12%
- The Goldman Sachs Group Inc1.13M1.98%
- Propel Bio Management LLC983.07K1.72%
- State Street Corp957.33K1.67%
- NAN FUNG TRINITY (HK) Ltd956.77K1.67%
- Awm Investment Company Inc803.13K1.40%
- 683 Capital Management LLC770.00K1.35%
- Stonepine Capital Management Llc746.59K1.31%
- SILVERARC CAPITAL MANAGEMENT, LLC648.94K1.13%
- J. Goldman & Co LP640.53K1.12%
Top Fund Holders
- Vanguard MStar Total Stk Mkt Idx Invest1.53M2.67%
- iShares Russell 2000 ETF1.17M2.04%
Dividends
Stock Splits
- Jul 5, 20221:25
- Oct 24, 20141:50
- Jun 5, 20061:5
- Jun 18, 19981:20
- Apr 16, 19921:2